Bristol-Myers Squibb Company BMY
$55.30▲ +0.40% 24H
Super Investor & Insider
8
Fondi che lo detengono
#57
Rank consenso
11.4%
% dei portafogli
$1.38B
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Richard Pzena · Pzena Investment Management | 3.37% | Reduce 4.72% | 17,095,731 | $1.04B |
| Dodge & Cox · Dodge & Cox | 0.15% | Reduce 34.69% | 4,622,820 | $280.4M |
| John Rogers · Ariel Investments | 0.49% | Reduce 1.49% | 721,731 | $43.8M |
| Kahn Brothers Group · Kahn Brothers Group | 1.83% | Reduce 15.73% | 170,381 | $10.3M |
| Bill Miller · Miller Value Partners | 1.1% | Reduce 35.65% | 69,500 | $4.2M |
| Hillman Capital Management · Hillman Capital Management | 2.24% | Reduce 1.6% | 53,102 | $3.2M |
| Tweedy Browne · Tweedy Browne | 0.13% | Add 55.31% | 26,158 | $1.6M |
| Mairs & Power · Mairs & Power | 0.01% | Reduce 2.96% | 24,200 | $1.5M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Bristol-Myers Squibb Company is a global biopharmaceutical company headquartered in Princeton, New Jersey, and founded in 1933. It discovers, develops, licenses, manufactures, markets, distributes, and sells innovative medicines addressing serious diseases worldwide. The company offers a diverse portfolio including sma…
SectorHealthcare
ExchangeNYSE
IndustryDrug Manufacturers - General
CountryUnited States
Employees32,500
TickerBMY
Statistics
Market Cap$112.91B
Revenue (TTM)$48.19B
Net Income$7.05B
Net Margin14.6%
EPS$3.46
P/E15.94
P/S2.40
P/B5.79
EV/EBITDA7.88
ROE38.7%
Dividend Yield4.41%
Price$55.30
Data: Twelve Data · Revenue = mcap / P/S